Perceptive Services, Inc. | Parexel International | New Jersey | state | 2005 | $685,125 | | grant |
Elanco Us Inc. | Elanco Animal Health | Iowa | state | 2015 | $684,174 | | training reimbursement |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2005 | $680,000 | | enterprise zone |
Eisai, Inc. | Eisai | New Jersey | state | 2005 | $677,820 | | Tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2017 | $677,616 | | tax credit/rebate |
Abiomed Inc. | Johnson & Johnson | Massachusetts | state | 2021 | $675,000 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2016 | $671,544 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2008 | $668,300 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2015 | $666,542 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2016 | $666,448 | | tax credit/rebate |
Acorda Therapeutics, Inc. | Acorda Therapeutics | New York | local | 2012 | $666,023 | | tax credit/rebate; property tax abatement |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2016 | $664,984 | | tax credit/rebate |
Abraxis BioScience | Bristol-Myers Squibb | Iowa | state | 2008 | $662,500 | | enterprise zone |
Doral/Pfizer | Pfizer | New York | local | 2007 | $662,163 | | tax credit/rebate; property tax abatement |
Regeneron Pharmaceuticals III | Regeneron Pharmaceuticals | New York | local | 2019 | $660,340 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2015 | $657,567 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2013 | $656,436 | | tax credit/rebate |
Regeneron Pharmacueticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2004 | $653,700 | | enterprise zone |
Novartis Vaccines & Diagnostics, Inc | Novartis | North Carolina | state | 2014 | $653,000 | | grant |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | Pennsylvania | state | | $650,000 | | grant |
Hospira inc | Pfizer | Kansas | state | 2013 | $650,000 | | grant |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2011 | $649,364 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2013 | $645,885 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2014 | $645,884 | | tax credit/rebate |
JANSSEN BIOTECH INC | Johnson & Johnson | Pennsylvania | state | 2020 | $644,100 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2015 | $641,296 | | tax credit/rebate |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2019 | $641,295 | | tax credit/rebate |
Merrimack Pharmaceuticals | Merrimack Pharmaceuticals | Massachusetts | state | 2014 | $633,361 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2022 | $632,089 | | tax credit/rebate |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2012 | $627,519 | | property tax abatement |
ImClone Systems Corporation | Eli Lilly | New Jersey | state | 1999 | $625,260 | | grant |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2018 | $624,705 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2015 | $623,585 | | tax credit/rebate |
Shire Holdings US, AG | Takeda Pharmaceutical | Pennsylvania | state | 2016 | $621,710 | | tax credit/rebate |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2001 | $620,000 | | enterprise zone |
United Therapeutics Corp | United Therapeutics | North Carolina | state | 2010 | $619,566 | | tax credit/rebate |
Amgen Inc. | Amgen | Pennsylvania | state | 2008 | $619,437 | | tax credit/rebate |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2015 | $617,069 | | property tax abatement |
BAUSH & LOMB | Bausch Health | South Carolina | state | 2010 | $615,965 | | training reimbursement |
Doral/Pfizer | Pfizer | New York | local | 2003 | $613,020 | | tax credit/rebate; property tax abatement |
Alnylam Pharmaceuticals | Alnylam Pharmaceuticals | Massachusetts | state | 2014 | $612,930 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2008 | $611,575 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Pennsylvania | state | 2016 | $608,743 | | tax credit/rebate |
Amgen, Inc. | Amgen | Pennsylvania | state | 2014 | $608,537 | | tax credit/rebate |
Millipore Corporation | Merck KGaA (EMD) | United States | federal | 2009 | $608,447 | | federal grant |
Pfizer, Inc. | Pfizer | North Carolina | state | 2012 | $607,213 | | tax credit/rebate |
Doral/Pfizer | Pfizer | New York | local | 2014 | $607,052 | | tax credit/rebate |
Bausch & Lomb R&D | Bausch Health | New York | local | 2006 | $605,264 | | tax credit/rebate; property tax abatement |
OSI Pharmaceuticals Inc | Astellas Pharma | New York | local | 2006 | $603,892 | | tax credit/rebate; property tax abatement |
HI TECH Pharmacal Company | Akorn Inc. | United States | federal | 2012 | $603,688 | | federal grant |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2021 | $603,374 | | tax credit/rebate |
Abbott Vascular Inc | Abbott Laboratories | California | state | 2021 | $603,200 | | training reimbursement |
GENENTECH, INC. | Roche | California | state | 2007 | $602,758 | | training reimbursement |
LAX/Amneal Pharmaceuticals | Amneal Pharmaceuticals | New York | local | 2017 | $600,562 | | tax credit/rebate |
Mylan Inc. | Viatris | Pennsylvania | state | | $600,000 | | grant |
Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals | New Jersey | state | 2011 | $600,000 | | grant |
AstraZeneca Pharmaceuticals LP | AstraZeneca | Indiana | state | 2017 | $600,000 | | tax credit/rebate |
Shire Human Genetic Therapies | Takeda Pharmaceutical | Massachusetts | state | 2014 | $597,076 | | tax credit/rebate |
Akorn, Inc. | Akorn Inc. | Illinois | state | 2015 | $596,900 | | tax credit/rebate |
Doral/Pfizer | Pfizer | New York | local | 2010 | $596,605 | | tax credit/rebate; property tax abatement |
Bristol Myers Squibb (Mr. Leon Squibb) | Bristol-Myers Squibb | New York | local | 2006 | $592,901 | | tax credit/rebate; property tax abatement |
Janssen Biotech, Inc. | Johnson & Johnson | Pennsylvania | state | 2016 | $591,853 | | tax credit/rebate |
GLAXOSMITHKLINE & Stiefel Laboratories Inc. | GlaxoSmithKline | New York | local | 2020 | $588,821 | | tax credit/rebate |
Shire Holdings US, AG | Takeda Pharmaceutical | Maryland | state | 2004 | $588,423 | | tax credit/rebate |
Ventana Medical Systems | Roche | Arizona | state | 2003 | $585,765 | | training reimbursement |
Chugai Pharma USA | Roche | New Jersey | state | 2004 | $582,225 | | grant |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $581,555 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2004 | $581,065 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2005 | $581,065 | | tax credit/rebate |
Aptalis Pharma US, Inc. & Aptalis Pharmatech, Inc. | AbbVie | New Jersey | state | 2008 | $579,072 | | grant |
Mylan Technologies, Inc. | Viatris | Vermont | state | 1999 | $576,729 | | tax credit/rebate; property tax abatement |
CSL Behring, LLC | CSL Limited | Pennsylvania | state | 2014 | $574,748 | | tax credit/rebate |
ImClone Systems Corporation | Eli Lilly | New York | state | 2011 | $574,259 | | enterprise zone |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | Pennsylvania | state | 2008 | $570,051 | | tax credit/rebate |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | New Jersey | state | 2011 | $569,910 | | grant |
Novartis Pharmaceuticals Corporation | Novartis | North Carolina | state | 2018 | $567,686 | | tax credit/rebate |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2011 | $566,948 | | tax credit/rebate |
GLAXOSMITHKLINE & Stiefel Laboratories Inc. | GlaxoSmithKline | New York | local | 2019 | $556,419 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2016 | $554,532 | | tax credit/rebate |
Gilead Sciences, Inc. | Gilead Sciences | North Carolina | state | 2011 | $550,523 | | tax credit/rebate |
Gilead Sciences, Inc. | Gilead Sciences | North Carolina | state | 2013 | $547,098 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2009 | $543,597 | | tax credit/rebate |
GLAXOSMITHKLINE & Stiefel Laboratories Inc. | GlaxoSmithKline | New York | local | 2017 | $540,625 | | tax credit/rebate |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2021 | $539,757 | | tax credit/rebate |
Janssen Research & Development, LLC | Johnson & Johnson | Pennsylvania | state | 2015 | $539,632 | | tax credit/rebate |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2009 | $538,000 | | enterprise zone |
Cambrex Charles City, Inc | Cambrex | Iowa | state | 2012 | $537,648 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2008 | $537,281 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc | Regeneron Pharmaceuticals | New York | Local | 2018 | $536,594 | | tax credit/rebate |
HOSPIRA, INC. | Pfizer | California | state | 2009 | $536,590 | | training reimbursement |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2019 | $536,362 | | tax credit/rebate |
GLAXOSMITHKLINE & Stiefel Laboratories Inc. | GlaxoSmithKline | New York | local | 2015 | $534,097 | | tax credit/rebate |
GLAXOSMITHKLINE & Stiefel Laboratories Inc. | GlaxoSmithKline | New York | local | 2016 | $534,097 | | tax credit/rebate |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | Maryland | state | 2017 | $534,013 | | tax credit/rebate |
Andrx Corporation, Inc. | Teva Pharmaceutical Industries | Florida | state | 2004 | $525,000 | | tax credit/rebate |
AbbVie Inc. | AbbVie | Massachusetts | state | 2016 | $525,000 | | tax credit/rebate |
Blueprint Medicines Corporation | Blueprint Medicines | Massachusetts | state | 2017 | $525,000 | | tax credit/rebate |
Genzyme Corporation | Sanofi | Florida | state | 2010 | $524,000 | | tax credit/rebate |
BioLife Plasma Services L.P. | Takeda Pharmaceutical | Idaho | state | 2011 | $523,620 | | training reimbursement |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | local | 2014 | $522,063 | | property tax abatement |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2015 | $521,964 | | tax credit/rebate |